The human gut contains trillions of microorganisms that shape metabolism, immunity, barrier function, and disease risk. Although scientists have long recognized the importance of the microbiome, turning that knowledge into predictive and clinically useful tools remains a major challenge. A new review published in Science China Life Sciences explores how close researchers are to building a “virtual gut” capable of predicting responses to diet, drugs, and microbiome-based therapies.
The review, titled “Integrating host-microbiome multi-omics with machine learning: methods, benchmarks, and translational applications,” was authored by researchers from Hunan Agricultural University, Yuelushan Laboratory, and the Institute of Subtropical Agriculture, Chinese Academy of Sciences. It argues that progress in microbiome science will depend not only on generating more data, but on integrating diverse omics data into models that are robust, interpretable, and biologically meaningful.
The article outlines a full analytical framework for host-microbiome multi-omics studies, covering preprocessing, feature selection, data integration, predictive modeling, and evaluation. It also reviews major machine learning approaches, including random forests, support vector machines, deep learning, graph neural networks, and large language models, showing how these tools can improve disease classification, treatment-response prediction, and the identification of key microbes, host factors, and regulatory pathways.
Importantly, the authors emphasize that model accuracy alone is not enough. To support real-world intervention, models must also be interpretable and experimentally testable. The review therefore highlights explainable AI methods and proposes closer integration between computational prediction and experimental platforms such as organoids, gut-on-a-chip systems, stable-isotope tracing, and spatial metabolomics.
One of the review’s most forward-looking ideas is the “virtual gut,” a computational framework that integrates molecular, cellular, clinical, and longitudinal data to simulate host-microbiome interactions. Such a system could eventually help predict individual responses to diet, probiotics, drugs, or synthetic microbial communities before intervention in real life. At the same time, the authors note that major challenges remain, including inconsistent study design, limited longitudinal data, incomplete benchmarking standards, and data-sharing constraints. Overall, the review presents a roadmap for moving microbiome research beyond descriptive analysis toward a more predictive, interpretable, and intervention-oriented future.
The article was published online. Dr. Haibo Shen, Dr. Longlin Zhang, and Dr. Xiaokang Ma are the co-first authors. Prof. Bi’e Tan and Prof. Jing Wang of Hunan Agricultural University, together with Prof. Yulong Yin of the Institute of Subtropical Agriculture, Chinese Academy of Sciences, are the co-corresponding authors.
Science China Life Sciences